Advertisement
CUE vs PCVX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Buy and PCVX is a StrongBuy.
CUE's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for CUE moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 35 of the 41 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 67 cases where CUE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +17.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where CUE advanced for three days, in 185 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CUE as a result. In 87 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CUE turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 46 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CUE moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CUE crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CUE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CUE entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. CUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CUE's P/B Ratio (57.612) is slightly higher than the industry average of (2.974). P/E Ratio (-0.622) is within average values for comparable stocks, (-0.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.903) among similar stocks. P/S Ratio (4.143) is also within normal values, averaging (439.237).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PCVX's Stochastic Oscillator remains in oversold zone for 7 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The 10-day moving average for PCVX crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in 225 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for PCVX moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 27 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PCVX as a result. In 59 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for PCVX turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 37 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
PCVX moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
PCVX broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PCVX entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.236) is normal, around the industry mean (2.974). P/E Ratio (-7.860) is within average values for comparable stocks, (-0.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. PCVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CUE | PCVX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 73 | |
SMR RATING 1..100 | 100 | 96 | |
PRICE GROWTH RATING 1..100 | 65 | 41 | |
P/E GROWTH RATING 1..100 | 12 | 51 | |
SEASONALITY SCORE 1..100 | 46 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PCVX's Valuation (20) in the null industry is significantly better than the same rating for CUE (93) in the Biotechnology industry. This means that PCVX’s stock grew significantly faster than CUE’s over the last 12 months.
PCVX's Profit vs Risk Rating (73) in the null industry is in the same range as CUE (100) in the Biotechnology industry. This means that PCVX’s stock grew similarly to CUE’s over the last 12 months.
PCVX's SMR Rating (96) in the null industry is in the same range as CUE (100) in the Biotechnology industry. This means that PCVX’s stock grew similarly to CUE’s over the last 12 months.
PCVX's Price Growth Rating (41) in the null industry is in the same range as CUE (65) in the Biotechnology industry. This means that PCVX’s stock grew similarly to CUE’s over the last 12 months.
CUE's P/E Growth Rating (12) in the Biotechnology industry is somewhat better than the same rating for PCVX (51) in the null industry. This means that CUE’s stock grew somewhat faster than PCVX’s over the last 12 months.
| CUE | PCVX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | 1 day ago 73% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| Advances ODDS (%) | 7 days ago 80% | 8 days ago 79% |
| Declines ODDS (%) | 1 day ago 90% | 2 days ago 71% |
| BollingerBands ODDS (%) | N/A | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 69% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CUE’s FA Score shows that 1 FA rating(s) are green while PCVX’s FA Score has 1 green FA rating(s).
- CUE’s FA Score: 1 green, 4 red.
- PCVX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CUE’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).
- CUE’s TA Score: 3 bullish, 6 bearish.
- PCVX’s TA Score: 3 bullish, 7 bearish.
Price Growth
CUE (@Biotechnology) experienced а +7.51% price change this week, while PCVX (@Biotechnology) price change was -8.39% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.36%. For the same industry, the average monthly price growth was -13.16%, and the average quarterly price growth was -14.28%.
Reported Earning Dates
CUE is expected to report earnings on Nov 11, 2026.
PCVX is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (-1.36% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CUE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CUE has been loosely correlated with VCYT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To CUE | 1D Price Change % | ||
|---|---|---|---|---|
| CUE | 100% | -0.70% | ||
| VCYT - CUE | 36% Loosely correlated | +4.32% | ||
| AXON - CUE | 33% Loosely correlated | +0.26% | ||
| AMRN - CUE | 32% Poorly correlated | -1.16% | ||
| ARRY - CUE | 31% Poorly correlated | +7.62% | ||
| PCVX - CUE | 29% Poorly correlated | +1.17% | ||
More | ||||
PCVX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with BCYC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then BCYC could also see price increases.
| Ticker / NAME | Correlation To PCVX | 1D Price Change % | ||
|---|---|---|---|---|
| PCVX | 100% | +1.17% | ||
| BCYC - PCVX | 57% Loosely correlated | +3.56% | ||
| VIR - PCVX | 46% Loosely correlated | +4.80% | ||
| NVAX - PCVX | 45% Loosely correlated | +6.60% | ||
| PTGX - PCVX | 44% Loosely correlated | +0.57% | ||
| ABUS - PCVX | 43% Loosely correlated | +2.14% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SMHX | 55.60 | 2.07 | +3.88% |
| VanEck Fabless Semiconductor ETF (SMHX) | |||
| TSME | 45.50 | 0.68 | +1.52% |
| Thrivent Small-Mid Cap Equity ETF (TSME) | |||
| ITDG | 42.39 | 0.27 | +0.65% |
| iShares LifePath Target Date 2055 ETF (ITDG) | |||
| IUSV | 115.61 | 0.21 | +0.18% |
| iShares Core S&P US Value ETF (IUSV) | |||
| CBOJ | 24.33 | 0.03 | +0.12% |
| Calamos Bitcoin Structured Alt Protection ETF - January (CBOJ) | |||